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The design of medical devices could be very much improved if robust tools were available
for computational simulation of tissue response to the presence of the implant. Such
tools require algorithms to simulate the response of tissues to mechanical and chemical
stimuli. Available methodologies include those based on the principle of mechanical
homeostasis, those which use continuum models to simulate biological constituents,
and the cell-centred approach, which models cells as autonomous agents. In the latter
approach, cell behaviour is governed by rules based on the state of the local environment
around the cell; and informed by experiment. Tissue growth and differentiation requires
simulating many of these cells together. In this paper, the methodology and applications
of cell-centred techniques—with particular application to mechanobiology—are reviewed,
and a cell-centred model of tissue formation in the lumen of an artery in response to
the deployment of a stent is presented. The method is capable of capturing some of
the most important aspects of restenosis, including nonlinear lesion growth with time.
The approach taken in this paper provides a framework for simulating restenosis; the
next step will be to couple it with more patient-speciﬁc geometries and quantitative
parameter data.
Keywords: cell-centred; lattice-based; restenosis; biological simulation; multi-scale model;
cellular automaton model
1. Introduction
The potential of computational models for understanding biological systems
is increasingly recognized, and their use in biomedical device design is
increasing. Gait analysis, modelling of hard and soft tissues, ﬂuid dynamics,
*Author for correspondence (pprender@tcd.ie).
Electronic supplementary material is available at http://dx.doi.org/10.1098/rsta.2010.0071 or via
http://rsta.royalsocietypublishing.org.
One contribution of 13 to a Theme Issue ‘The virtual physiological human: computer simulation
for integrative biomedicine II’.
This journal is © 2010 The Royal Society 29192920 C. J. Boyle et al.
etc. have enabled characterization of the mechanical function and dysfunction
of the human body across many length scales, as can be seen, for example,
from the progress made in the virtual physiological human (VPH) initiative
(http://www.vph-noe.eu/vph-initiative). The VPH initiative has successfully
elaborated on the functional complexity of many biomechanical systems, for
example the cardiac system (Kohl & Noble 2009). One complexity that is central
to biomechanical systems is their ability to alter their structure (through growth
and differentiation)—there is much scope to address this type of complexity
within the VPH project. Many of the most common health issues in the skeletal
and cardiovascular systems stem from the property of adaptation over medium
(weeks) to long (years) time scales, such as osteoporosis, cardiovascular diseases,
developmental abnormalities, wound/fracture healing, ageing and biomedical
device failure. The biomechanical system can adapt by changing its shape, such
as in bone remodelling, hypertension-induced arterial narrowing and tumour
growth, or by altering the mechanical properties of the constituent materials, e.g.
tissue differentiation and atherosclerosis. Mechanics plays a key role in regulating
this adaptation: mechanobiological models are required to capture the long-term
behaviour of the system, and if such models can be successfully corroborated, it
opens one way to improve the design of medical devices.
Tissue adaptation can be represented as a system striving to achieve a
homeostatic mechanical state by altering its geometry (growth/resorption) or
material properties (stiffness, porosity, etc.). This concept has been successfully
applied to bone remodelling (Cowin & Hegedus 1976; Huiskes et al. 1987;
Prendergast & Taylor 1994) and arterial remodelling (Rachev et al. 2000;
Kuhl et al. 2003; Alastrue et al. 2008). However, this concept of reverting
to a supposed homeostatic equilibrium hides a complexity because adaptation
processes are indirectly related to mechanics, through complex systems of cells,
tissue and chemical signals. In skeletal tissue differentiation, for example, the
differentiation of mesenchymal stem cells is mechanoregulated, producing a
complex link between mechanics and tissue adaptation. This complexity led to
the explicit inclusion of cell activity in mechanobiology, where cell behaviours
such as proliferation, differentiation and migration were modelled with differential
equations (Lacroix et al. 2002; Bailon-Plaza & van der Meulen 2003; Lally &
Prendergast 2004), or where cell activity was indirectly modelled through
evolution equations (Zohdi et al. 2004; Ruimerman et al. 2005). Continuum
assumptions break down at the level of the cell, which are typically 10–100 μm
in diameter. In arteries, which are of the order of 500 μm thick, this means the
organ may only be 5–50 cells thick.
The hierarchical structure of biomechanical systems permits modelling at
various length scales; from the tissue level, through the cell level to the molecular
level. Formulating the model at the tissue level requires a phenomenological
link between stress and adaptation which may be a highly complex relationship.
Indeed, there may be no adequate equations available to model this relationship.
At this level, the system is slow to react to the mechanical environment; it reacts
over months, whereas at the other extreme, mechanics affect the system very
rapidly, by opening ion channels, or altering the morphology of the cells. Models
at this level would be the most complex, as all intercellular and extracellular
processes would be important, and modelling them would quickly become
unmanageable. At the level of the cell, we can postulate that mechanics affects
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the behaviour of cells, i.e. by regulating differentiation, apoptosis, proliferation,
etc. One major beneﬁt of this approach is that much of experimental biology
is focused on this level (Prendergast et al. 2009; Checa et al. 2010). The key
to effective modelling of tissue adaptation is a multi-scale approach (Evans et al.
2008)—where processes at the continuum/tissue level (for example stress/strain),
and at the intercellular level (perhaps gene transcription) can inform processes
at the cell level (differentiation, proliferation, etc.).
2. Neointima formation
Muscular arteries are tubular vessels of smooth muscle surrounded by an
endothelium on the inner surface. Atherosclerosis is an asymmetric focal
thickening of the artery wall, which can lead to occlusion, depriving downstream
tissues of oxygen, which can lead to myocardial infarction or stroke. Stents have
become one of the most popular treatment techniques; however, different stents
produce different amounts of restenosis (Hoffmann et al. 2001, 2002; Morton
et al. 2004). Restenosis is due to tissue in-growth into the lumen as a result of
injury to the vessel wall imparted by the expanded stent. The smooth muscle cells
(SMCs) which populate the artery wall have complex behaviours, but a simpliﬁed
description (see Thyberg et al. 1990) is the following.
— SMCs can exist in two distinct phenotypes: contractile (cSMC) and
synthetic (sSMC). The cSMCs exist in the uninjured tissue, and remain
quiescent (do not proliferate or synthesize matrix) unless the extracellular
components are disrupted.
— If the extracellular matrix (ECM) in injured regions is disrupted/degraded,
cSMCs modulate their phenotype and become synthetic—producing ECM
and responding to growth factors by proliferating.
Neointima formation in response to injury can be simpliﬁed into distinct,
overlapping phases (Drasdo et al. 1995; Evans et al. 2008). An exudative phase
occurs when macrophages and other inﬂammatory cells aggregate around and
within the injury site from the blood. They initiate a resorptive phase where
debris, tissue and dead cells are decomposed by inﬂammatory cells. These cells,
together with the dead SMCs and endothelial cells (ECs) produce growth stimuli,
which initiate the proliferation phase where SMCs proliferate and inﬁltrate the
injured region, depositing granulation tissue. The repair phase then consists
of deposition of collagen-based tissue in place of the granulation tissue. The
endothelium is inﬂuential in providing a mechano-sensitive barrier between
the smooth muscle and the blood, and can also actively signal SMCs. This
layer is damaged (often removed completely) during stent deployment and its
growth-inhibitory effects are only restored when the layer re-heals.
The above description is a simpliﬁed, mechanistic description of the process
of neointima formation in the artery. In this paper, we explore the use of the
cell-centred approach to develop a predictive model for restenosis. We apply the
approach to restenosis development within an artery after implantation of a stent,
and explore the impact of EC proliferation rate on the development of restenosis.
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3. Theoretical framework of cell-centred methodologies
Cell-centred approaches to adaptation aim to reproduce the complex dynamics
of the biological system through modelling the behaviour of individual cells.
They require a representation of cells (spatial and behavioural), and may include
environmental variables (biochemical factors, ECM molecules, mechanics). The
system is incremented by applying behavioural rules to cells based on the local
environment.
In reality, cells are discrete entities and have a complex and dynamic structure.
When producing discrete cell-based models, some coarsening/simpliﬁcation of the
cell structure is necessary. Lattice-based methods discretize the spatial domain
into a regular orthogonal grid of points, in which case the cells occupy either
individual unique nodes (like a cellular automaton; Peréz & Prendergast 2007),
or occupy several adjacent nodes, as in the cellular Potts model (CPM; Graner &
Glazier 1992; Glazier & Graner 1993; Izaguirre et al. 2004; Cickovski et al.
2005; van Oers et al. 2008a,b), explained below. In non-lattice-based approaches
(Drasdo et al. 1995; Walker et al. 2003), the cells have a deﬁned location
in continuous space, and a volume associated with this. In this approach,
the neighbourhood must be searched using spatial search algorithms, such as
octrees, which means, for large numbers of cells, the computation time of
non-lattice techniques can grow massively. The lattice approach offers a less
computationally expensive method, as it provides a grid within which the
model variables are deﬁned, meaning that the sampling of the environment is
reduced to sampling adjacent lattice sites. Non-lattice techniques allow more
complexities, like growth forces (Walker et al. 2003), cell deformations and
growth (Drasdo et al. 1995), to be dealt with. The decision over which of
these representations to use will be based on the length scale and size of
the problem.
Components, such as diffusible chemicals, ECM, etc. and biophysical stimuli,
such as strain and ﬂuid ﬂow, can be represented as spatial ﬁelds. Field variables
can be implemented as having continuously varying values at discrete points and
can be deﬁned at the points of the cell lattice (in structured grids), or interpolated
from a separate grid, such as a ﬁnite element mesh (Byrne 2008). Mapping from
coarser grids in this way enables multi-scale modelling of biophysical stimuli that
may be more suited to a coarser representation while retaining sufﬁcient biological
detail to model processes of interest at the cellular level.
Cell types relevant to most mechanobiological models have a limited set
of behaviours: proliferation, migration, differentiation, absorption/expression of
chemicals and apoptosis. Cells move through tissue by crawling. Cell migration
can be represented as a random walk process. This can include a random direction,
a random distance, and can be isotropic or chemo/haptotactic. Random walk
within a lattice is implemented by allowing the discrete cells to jump to available
neighbouring positions (selected at random—or biased along the gradient of
a stimulus). The CPM, developed by Glazier and Graner (Graner & Glazier
1992; Glazier & Graner 1993) from a lattice-based model for grain-coarsening
in metals, represents cell movement as a ﬂuctuation of the cell boundary where
lattice points are added/removed from the cell at random, provided the change
meets requirements for cell volume and surface area. The cell cycle itself can be
implemented, where cells pass through phases based on time and external cues.
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Non-lattice-based methods can use an overlapping force technique to represent
the multi-body mechanics of cell growth, allowing cells to overlap and exert forces
on their neighbours. This may be important to study residual stress formation
during tissue growth. These behaviours are then implemented as explicit updating
procedures.
In lattice-based approaches, every lattice point can be operated upon
sequentially or randomly; however, when the lattice is dense and sparsely
populated, this can be inefﬁcient. Instead, a list of cells in the lattice can be
computed at the beginning of a simulation, and the simulation operates on
each cell in the list. Non-lattice-based approaches also operate on each cell in
the model; however, spatial searching of an unstructured space must be used
(see above).
The cell-centred technique is extremely versatile, and has been used to simulate
a wide variety of biological systems. Developmental processes, cell sorting and
tumour growth have been simulated using the CPM (see the review by Merks &
Glazier 2005). Dermal wound healing has been simulated in three dimensions
and wound healing assays have been simulated using agent-based techniques
(Walker et al. 2003; Mi et al. 2007; Simpson et al. 2007). The lattice-based
approach has been used in a wide variety of mechanobiological models. Peréz &
Prendergast (2007) were the ﬁrst to use the random walk approach for cell
proliferation and migration in a simulation of tissue differentiation. In this
model, the migration and proliferation of mesenchymal stem cells were simulated
in a lattice. Finite element analysis was performed at regular intervals to
determine the mechanical stimuli of ﬂuid ﬂow and shear stress, which regulated
the differentiation of these cells into osteoblasts, chondrocytes or ﬁbroblasts,
following the theory proposed by Prendergast et al. (1997). These differentiated
cells produced their characteristic tissues, which then altered the mechanical
properties of the tissue, and hence the stimulus. In this way, the time-course of
tissue differentiation could be captured in a simulation. This was later applied to
idealized bone scaffolds (Byrne et al. 2007), fracture healing (Byrne 2008), tissue
differentiation in a bone chamber (Khayyeri et al. 2009), and tissue differentiation
with angiogenesis (Checa & Prendergast 2009). In that study, angiogenesis was
included by modelling the capillaries as sprouts of adjacent ECs. These then
inﬂuenced tissue differentiation, as bone formation was assumed to only occur
within a speciﬁed distance of an oxygen source (capillary). Van Oers et al.
(2008a,b) have used the CPM to simulate osteon formation, and bone remodelling
through the explicit modelling of osteoclast behaviour. In this model, osteoclasts
are assumed to attach to bone sites where a mechanical stimulus signal (sensed by
osteocytes in the bone) is low. Osteoblasts produced bone at the newly exposed
surface. Osteonal remodelling then occurred through the sequential resorption
and deposition of bone.
Preliminary results from the COAST project (www.complex-automata.org)
have shown the possible power of a multi-scale, multi-physics model of restenosis
development (Caiazzo et al. 2009). Blood ﬂow, structural stress and diffusion
from a stent were simulated and combined with an agent-based model of
SMC behaviour in two dimensions. This model assumed that SMC proliferation
was governed by local ﬂuid ﬂow, structural stress and drug concentration.
A tumour-like growth pattern was found, which was inhibited by the presence
of drugs.
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As the cell-centred methodology matures, it will ﬁnd more applications, as it
has the ability to incorporate a maximal amount of experimental information.
In the next section, a cell-centred approach is applied to restenosis development
within an artery due to stenting.
4. Application to neointima development
A cell-centred model of an idealized human coronary artery was implemented
using a lattice-based approach. Three cell types (cSMCs, sSMCs and ECs), and
three extracellular components (ECM, matrix degrading factors (MDF), and
growth stimuli (G)) were modelled. The SMC phenotype was governed by the
local ECM concentration: it was contractile if the ECM was present and not
degraded (ECM = 1) and the local concentration of cells was below a critical
value cSMC,crit, and synthetic otherwise. This ensured that a region would return to
quiescence when the ratio between cells and ECM was appropriate. Differentiation
was assumed to be reversible. sSMCs proliferated if the local growth stimulus
was above a critical level (Gcrit), and occurred at a constant rate (pSMC). A
successful proliferation reduced the local growth stimulus by Gcrit. Migration of
sSMCs occurred in random directions at a constant rate (vSMC) through lattice
points which either had or were adjacent to points with ECM present. sSMCs
produced ECM at a constant rate (cECM) at their lattice position. In lattice points
containing both ECM and MDF, both of these components were reduced at a
constant rate of degradation, cdeg. ECs were only allowed to occupy lattice points
which fulﬁlled the following conditions: they did not contain ECM, and they
were adjacent to a lattice point with ECM, i.e. ECs could only proliferate along
the lumen surface, and occurred at a constant proliferation rate, pEC. A system
diagram of the simpliﬁed system implemented is given in ﬁgure 1. The lattice was
updated according to these rules over time, as shown schematically in ﬁgure 2.
At each time increment, all cells were operated upon based on their phenotype.
Random walk migration and proliferation were performed on each active cell a
number of times per increment based on the migration and proliferation rates,
respectively. Differentiation of SMCs and ECM production were performed every
increment, with the increment corresponding to one day. Depending on the
particular initial conditions and parameters of the model, this simulation can
progress until equilibrium is reached, i.e. when the endothelium is completely
healed, or until the lumen is entirely occluded. SMCs cannot occupy a lattice
point containing another cell, so a position occupied by an EC represents an
immovable and impenetrable barrier to SMCs.
Finite element analysis was performed and coupled with an injury threshold to
quantify injury in the artery wall due to stenting. The artery was modelled as a
hollow cylinder with a length of 14 mm and inner and outer diameters of 2.5 and
3.75 mm, respectively. Following Gervaso et al. (2008), the material properties of
the artery were represented as a third-order Mooney–Rivlin hyperelastic model
based on circumferential, uniaxial tests carried out on non-diseased media from
human coronary arteries with intimal thickening by Holzapfel et al. (2005).A
four-crowned, corrugated-ring, stainless-steel stent was modelled with similar
designs to those used by Garasic et al. (2000); the ﬁnite element (FE) mesh
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Figure 1. A system diagram of the components (in boxes) and processes (arrows) involved in the
model of smooth muscle cell behaviour. (i) The uninjured artery wall is quiescent and contains
contractile smooth muscle cells (cSMCs) and extracellular matrix (ECM). Injury induces cell death
and tissue damage/rupture. (ii) In response, inﬂammatory cells inﬁltrate the injured region and
produce matrix degrading factors and growth factors. (iii) Matrix degradation of ECM induces (iv)
SMCs to modulate their phenotype from contractile to synthetic (sSMC). These sSMCs proliferate
in response to growth factors (G) (v) and express ECM (vi). SMCs can resort back to the contractile
phenotype if the ECM is fully restored.
of the expanded and unexpanded stent is shown in ﬁgure 3. The stent was
modelled as a bi-linear elasto-plastic material with the properties of stainless
steel (Early et al. 2009). Physiological conditions in the artery were simulated
by applying an axial pre-stretch of 1.2 and a blood pressure of 13.3 kPa prior
to stent expansion. A radial displacement was applied to all nodes of a cylinder
within the stent, expanding it from an initial diameter of 1.15 to 3.3 mm. This
achieved an expansion ratio of 1.2. The cylinder was retracted allowing recoil of
the stents. To reduce the simulation times, symmetry was used to reduce to a
1/8th model circumferentially (ﬁgure 3). Appropriate boundary conditions were
applied along the planes of symmetry. The simulations were run using ABAQUS
(SIMULIA) to determine the stresses in the artery following stent expansion.
In order to map stress from the FE mesh onto the lattice, the lattice bounds
were initialized to encompass the entire FE mesh. For each element in the FE
mesh, the lattice points within that element were found following the method
of Byrne (2008). Brieﬂy, a bounding box was formed around each element, with
each lattice point within this box tested to check if it fell within all six faces of
the element. These points were initialized as artery lattice points by assigning
the stress value of the element and by initializing them with ECM = 1. cSMCs
were randomly distributed within a certain percentage (cSMC) of the arterial
lattice points. Injury was assumed to occur above a critical threshold of minimum
principal stress. At lattice points with a stress above this value, cells were removed
and initial conditions for G and MDF were introduced (table 1). These represent
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Figure 2. Schematic diagrams of the rules governing cell activity in the lattice model. (a) SMCs
surrounded by ECM and with an intact endothelium express a contractile phenotype, (b) ECM is
reduced in injured areas, simulating the degradation of ECM by MDFs, and SMCs are removed (c).
cSMCs neighbouring the reduced ECM region modulate to the synthetic phenotype, (d) sSMCs
migrate by random walk (arrows indicate possible movements) and (e) proliferate (dashed lines
indicate daughter cells), (f) ECM is produced by cells as they move, and (g) over time a lesion forms
until (h) the endothelium has healed. A video of this process in action is included as the electronic
supplementary material, video S1 (green circles, cSMC; blue circles, sSMC; red circles, EC).
(a)( b)
Figure 3. Finite element mesh of the unexpanded stent (a) and after expansion in a cylindrical
artery (b). For computation, the stent and artery were reduced down to a 1/8 model in the
circumferential direction, the modelled portion of the geometry can be seen in red.
an acute source of injurious factors, and encompass production from SMCs,
EC, platelets and inﬂammatory cells. ECs were initialized to cover the lumen
surface proximal and distal to the stent ends, simulating total denudation
within the stented region, as has been found for balloon-expanded stents
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Table 1. Parameter estimates used in the baseline simulation.
parameter symbol (units) value
lattice spacing dl (mm) 0.01825a
stress threshold scrit (kPa) 35 (compressive)b
initial smooth muscle cell concentration cSMC,init (cellsmm−3) 3.16 × 104c
smooth muscle cell migration speed vSMC (mmd−1) 0.24d
smooth muscle cell proliferation rate pSMC (mitosesd−1) 0.24a
endothelial proliferation rate pEC (mitosesd−1)2 e
initial matrix degrading factor MDFinit (dimensionless) 1e
extracellular matrix degradation rate cdeg (dimensionless) 0.05e
extracellular matrix production rate (dimensionless) 0.20e
initial growth factor G (dimensionless) 3a
aSchwartz et al. (1996).
bLinder-Ganz et al. (2006).
cTracy (1997).
dDiMilla et al. (1993).
eChosen to agree with time-course of restenosis studies/reviews (Edelman & Rogers 1998; Orford
et al. 2000; Bennett & O’Sullivan 2001; Welt & Rogers 2002).
(Harnek et al. 1999). The model assumes endothelium heals through proliferation
of healthy ECs in neighbouring regions to the stent. The simulation was then
run for an equivalent of 320 days post-stenting. The neointimal area at an axial
position within the stent was calculated as the area of lattice points containing
ECM minus the initial cross-sectional area of the artery. The volume of the lesion
was calculated as the sum of these areas over the length of the artery. Cell numbers
were counted, and the cumulative population doubling of the cells per day was
calculated (measuring overall proliferation rate) as log2(N/N0), where N is the
current number of cells and N0 is the previous day’s cell number.
The model parameters were selected based on experimental values, calibrated
against experiments or selected based on the descriptions of the time-course of
neointima development. DiMilla et al. (1993) measured the migration speed of
individual human SMCs on various substrates in vitro and found the speed to be
of the order of 10–20 μmh−1. The proliferation dynamics of SMCs in the artery are
controlled by the proliferation rate and amount of initial growth stimulus. These
parameters were selected to produce a similar proliferation proﬁle to human SMCs
(Schwartz et al. 1996). Matrix degradation was assumed to completely resorb
damaged tissue (in the absence of matrix producing cells) after 20 days. The
endothelial healing rate was selected to achieve re-endothelialization of an 8 mm
denuded artery after 180 days (giving pEC =2). Due to the large variation in this
parameter, it was varied over a wide range (proliferation attempt rate of 0–4 per
cell per day). The lattice density represents the maximum cell density possible.
This was set to 1.64 × 105 cells per mm3, based on human cell concentrations in
neointima (Schwartz et al. 1996). The initial concentration of SMCs was based
on cell concentrations in human artery tissue (Tracy 1997), and set to 3.16 × 104
cells per mm3. Experiments on skeletal muscle have shown that the threshold
of compressive stress for skeletal muscle cell viability is between 35 and 70 kPa
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(Linder-Ganz et al. 2006), and the lower limit of 35 kPa was used as the injury
threshold (scrit) for arterial smooth muscle in the simulations presented here.
Parameters are summarized in table 1.
5. Results
Injury was predicted under stent struts, with the highest injured volumes at the
stent ends and at stent cell junctions. ECM degradation in these regions induced
phenotype modulation to sSMCs in surrounding cSMCs. These sSMCs migrated
into the injured regions and proliferated to ﬁll up the injured space (ﬁgure 4,
day 7) eventually leading to lesion growth (ﬁgure 4, days 90 and 160). Lumen
narrowing was arrested in two ways. In regions where the injured volume was
small, such as in the centre of the stent, sSMCs modulated back to the contractile
phenotype. In regions with a large injured volume, such as at the ends of the
stent, the amount of sSMCs was greater, and lumen narrowing did not stop until
the healing endothelium covered it (ﬁgure 4, day 320). In this region, SMCs did
not return to their contractile phenotype within the duration of the simulation.
The lesion grew rapidly in the ﬁrst 90 days for all simulations (ﬁgure 5). For
high pEC rates, the lesion growth then slowed to a stop when the endothelium
healed (approx. 180 days), whereas for low pEC rates the growth rate simply
slowed (ﬁgure 5). The ﬁnal distribution of the lesion was also highly dependent
on endothelial proliferation rate, with low healing rates associated with focal
thickening at the ends of the stent and high healing rates producing maximal
lesion size at the centre of the stent (ﬁgure 6). The proliferation rate over time
of the artery was largely unaffected by changes in pEC; all simulations produced
a peak in proliferation early on, followed by a gradual reduction in proliferative
activity (ﬁgure 7).
6. Discussion
Many of the structural changes that biological systems undergo are complex, and
are a result of many biological components interacting. It has been argued that
producing mathematical laws governing such a complex system is difﬁcult: ‘to do
so would be like expecting to discern the fundamental laws of electromagnetism
in the output of a personal computer’ (Lander 2004), indeed, no such laws may
exist. An alternative is to break up the system, until the components begin to
behave according to simple models. The extreme of this path is to reduce down to
the molecular level, where reaction–advection–diffusion equations govern. Even
if this were possible for any relevant model size, it may not be useful, as the
model system would be just as complicated as the reality (Merks & Glazier
2005). The cell is a natural level of abstraction, as they are discrete entities
and their behaviour can be reduced to a simple set of rules. They process inputs
such as extracellular environment, mechanical stimuli and chemical stimuli, and
regulate their behaviour accordingly to migrate, proliferate, secrete extracellular
components, produce force, apoptose, etc. The aim of the modeller is then to
develop a sufﬁciently accurate model of individual cell behaviour that, when
combined with many cells in a simulation, produces a robust, and accurate,
tissue-level model.
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Figure 4. The expanded stent within the artery (top). The region bound by the dashed box was
monitored for cell states over the simulation. At day 7, sSMCs are active in the injured region. The
lesion progresses until the endothelium covers the tissue (arrow, day 160) or until the SMCs resort
to their contractile phenotype (arrow, day 320). Simulation shown is for endothelial proliferation
rate, pEC = 2 (green, cSMC; blue, sSMC; red, EC).
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Figure 5. As the endothelial cell proliferation rate increases, the volume of neointima produced
reduces (pEC = 0 (ﬁlled circle), pEC = 1 (open circle), pEC = 1.5 (ﬁlled triangle), pEC = 2 (open
triangle), pEC = 2.7 (ﬁlled square), pEC = 4 (open square)).
The example described here has some limitations. The geometry of the problem
was simpliﬁed to a cylinder, whereas in patients, a signiﬁcant stenosis with
heterogeneous properties would affect the calculations of stress (and therefore
injury) in the artery (Kiousis et al. 2007; Gijsen et al. 2008). Compressive
stress was chosen as the stimulus causing tissue injury; however other variables
such as strain, tensile stress or strain energy density may better predict
injury/damage/cell death. More information is needed on the relationship
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Figure 6. As endothelial proliferation rate decreases, maximum neointima at the stent ends at 320
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Figure 7. Proliferation rate, measured as cumulative population doublings of neointimal SMCs per
day in the artery over time, for pEC = 2. Endothelial healing rate was found to have minimal effects
on the proliferation proﬁle of the artery (results for other values of pEC not shown for clarity).
between mechanics and initial injury. The inﬂammatory response was modelled
only as an initial condition of MDFs and growth factors. In reality this is a
complex response, which occurs as monocytes, macrophages and platelets invade
the injured zones from the lumen and act locally to remove debris and stimulate
SMCs. This process may need to be modelled more explicitly by including
macrophages. The parameters for the behaviours of the cells in the system have
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been taken from in vitro and in vivo data from various species. These parameters
have an effect on the outcome of the simulations, and will need to be explored
experimentally. The endothelium healing rate was found to have a large effect on
the amount of restenosis. Endothelial proliferation rate varies considerably, and
the healing rate is dependent on the injury of the underlying tissue (Kipshidze
et al. 2004), underlying substrate strain (Moretti et al. 2004) and ﬂuid ﬂow-
induced shear stress (Zarins et al. 1987; White et al. 2001; Resnick et al. 2003;
Wentzel et al. 2003). The endothelium model implemented here represented
a healed endothelium as a rigid, physical barrier to growth. In reality, the
endothelium inhibits growth by acting as a barrier to growth stimuli, and
underlying tissue can continue to grow. However, even with such simpliﬁcations,
the simulation could capture important characteristics of lesion growth found in
vivo in the following ways: lesion development was found to be nonlinear in time;
unevenly distributed within the stent; and the endothelial healing rate was found
to have a large effect on the progression of restenosis. In the future, a method for
allowing sub-endothelial growth could be implemented by allowing displacement
of ECs by smooth muscle.
This is very much a physiomic modelling approach, allowing the synthesis
of a diverse range of information. Components may be studied in relative
isolation, allowing the implementation of in vitro work, and the cell models
should be generic enough to apply to a range of applications. The cell models
underlying the cell-centred techniques must be based on sound rules, extracted
from experimental observation, as the model behaviour is a product of these rules.
One current limitation of the cell-centred technique when applied to restenosis
is the paucity of quantitative information on the dynamics of the system. However,
if the loop between experimentation and theory is to be followed, more data
are needed on key behaviours of cells within their natural environments rather
than in vitro. This would require a benchmark experiment which is controlled
to the highest degree possible; such experiments have informed skeletal tissue
differentiation models (Khayyeri et al. 2009). Until such data are available, the
simulation methodology is useful in exploring the possible behaviours of the
system (Peck 2004).
A key beneﬁt of including more biological processes in a model of tissue
adaptation is the ability to make predictions about what happens when these
processes are altered by the presence of an implant. As biomedical devices
become more biologically active (such as drug-eluting prostheses or tissue-
engineered implants), predictions from traditional models become more difﬁcult.
Also, biological parameters can be highly variable between patients, meaning a
pure mechanical analysis may not accurately predict a device’s behaviour in a
population, as each patient’s reaction to an identical stimulus will be different.
Including biology allows the effect of this source of variation on the system to
be studied. The COAST project aims to include growth-inhibiting drug diffusion
in a multi-scale, multi-science model of restenosis development. The preliminary
work assumes SMC proliferation is induced in response to high structural stress,
or low wall shear stress, providing contact inhibition and drug concentration are
acceptable. In contrast, the model described here includes explicitly the ECM
(which constitutes a large proportion of restenotic tissue), growth factors (which
control SMC proliferation, are diffusible, locally expressed and often short lived)
and endothelium (which is inﬂuential in regulating smooth muscle tissue activity).
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The inclusion of these complexities provides a cell-centred model whose rules
are based on the known biological mechanisms of restenotic tissue development.
The regulatory effects of mechanical stimuli can then be implemented through
a known/postulated link, such as wall shear stress regulating the production of
growth factors at the lumen surface, or tissue stress inducing cell death and
subsequent inﬂammation.
The gold standard for preclinical testing is currently still animals, particularly
in predicting the medium to long-term response to an implant. However, their
limitations in many key applications have been increasing. Their biological and
mechanical systems are not accurate in predicting performances in many cases
(see, for example, the review of animal models on drug-eluting stents by Schwartz
et al. 2004). Provided that methodologies are adopted which can synthesize
the independent islands of knowledge, computational models may well overtake
animal models in the prediction of tissue adaptation.
7. Conclusions
Cell-centred methodologies have proven insightful and predictive in many diverse
areas of biological system modelling, and represent a promising paradigm for
including some of the temporal aspects of the VPH project.
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